XOMAP Q3 2023 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$311M

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$830,000+84.0% YoY

Gross Profit

$805,00097.0% margin

Operating Income

-$6M-697.2% margin

Net Income

-$6M-663.7% margin

EPS (Diluted)

$-0.60

QoQ Revenue Growth

-49.9%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$124M

Total Liabilities

$18M

Stockholders' Equity

$106M

Cash & Equivalents

$33M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$830,000	$451,000	+84.0%
Gross Profit	$805,000	$422,000	+90.8%
Operating Income	-$6M	-$4M	-32.4%
Net Income	-$6M	-$4M	-31.9%